DuChemBIO Co.,Ltd. (KOSDAQ:176750)
 9,500.00
 -70.00 (-0.73%)
  At close: Oct 27, 2025
DuChemBIO Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
 Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | 
|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | 
| Cash & Equivalents | 13,080 | 10,690 | 1,970 | 
| Short-Term Investments | - | - | 11.06 | 
| Cash & Short-Term Investments | 13,080 | 10,690 | 1,981 | 
| Cash Growth | - | 439.69% | - | 
| Accounts Receivable | 10,666 | 9,650 | 8,330 | 
| Other Receivables | 601.42 | 530.51 | 773.01 | 
| Receivables | 11,267 | 10,181 | 9,103 | 
| Inventory | 1,280 | 1,304 | 1,307 | 
| Prepaid Expenses | 40.54 | 17.3 | 22.96 | 
| Other Current Assets | 17.47 | 47.47 | 254.36 | 
| Total Current Assets | 25,685 | 22,240 | 12,668 | 
| Property, Plant & Equipment | 15,753 | 16,712 | 16,186 | 
| Long-Term Investments | 3,212 | 3,339 | 2,125 | 
| Goodwill | 10,108 | 10,108 | 10,108 | 
| Other Intangible Assets | 8,236 | 8,725 | 7,281 | 
| Long-Term Accounts Receivable | 370.69 | 398.07 | - | 
| Long-Term Deferred Tax Assets | 2,571 | 2,562 | - | 
| Other Long-Term Assets | 1,110 | 1,085 | 659.66 | 
| Total Assets | 67,046 | 65,168 | 49,277 | 
| Accounts Payable | 1,924 | 1,183 | 1,276 | 
| Accrued Expenses | 8.79 | 19.07 | 15.69 | 
| Short-Term Debt | 3,014 | 3,614 | 8,240 | 
| Current Portion of Long-Term Debt | 3,943 | 4,343 | 3,943 | 
| Current Portion of Leases | 2,806 | 3,028 | 2,543 | 
| Current Income Taxes Payable | 384.32 | 100 | 92.17 | 
| Other Current Liabilities | 2,810 | 2,637 | 3,248 | 
| Total Current Liabilities | 14,890 | 14,925 | 19,357 | 
| Long-Term Debt | - | - | 1,200 | 
| Long-Term Leases | 6,500 | 6,566 | 5,830 | 
| Pension & Post-Retirement Benefits | 876.95 | 668.11 | 1,095 | 
| Other Long-Term Liabilities | -0 | - | 0 | 
| Total Liabilities | 22,267 | 22,159 | 27,482 | 
| Common Stock | 14,603 | 14,228 | 13,513 | 
| Additional Paid-In Capital | 18,270 | 18,270 | 7,424 | 
| Retained Earnings | 12,650 | 10,925 | 2,958 | 
| Treasury Stock | -1,165 | -1,165 | -2,887 | 
| Comprehensive Income & Other | 421.49 | 376.64 | 411.86 | 
| Total Common Equity | 44,779 | 42,635 | 21,419 | 
| Shareholders' Equity | 44,779 | 43,010 | 21,794 | 
| Total Liabilities & Equity | 67,046 | 65,168 | 49,277 | 
| Total Debt | 16,263 | 17,551 | 21,755 | 
| Net Cash (Debt) | -3,183 | -6,861 | -19,775 | 
| Net Cash Per Share | -115.06 | -255.39 | -739.20 | 
| Filing Date Shares Outstanding | 28.34 | 28.34 | 26.75 | 
| Total Common Shares Outstanding | 28.34 | 28.34 | 26.75 | 
| Working Capital | 10,795 | 7,315 | -6,689 | 
| Book Value Per Share | 1579.81 | 1504.15 | 800.68 | 
| Tangible Book Value | 26,435 | 23,801 | 4,031 | 
| Tangible Book Value Per Share | 932.63 | 839.71 | 150.67 | 
| Machinery | 50,407 | 50,127 | 49,396 | 
| Construction In Progress | 211.9 | 103.5 | 396.35 | 
Source: S&P Global Market Intelligence. Standard template. Financial Sources.